期刊文献+

LC-MS/MS测定人血浆中莫沙必利的浓度

Determination of Mosapride in Human Plasma Using LC-MS/MS Method
下载PDF
导出
摘要 目的建立人血浆中莫沙必利测定的方法。方法采用LC-MS/MS分析,色谱柱为00B-4454-B0(Gemini 5mNX-C 18110,50×2mm),流动相A为0.2%FA的水溶液,流动相B为0.2%FA的95%ACN溶液。结果在0.200~160ng·mL^-1范围内,莫沙必利峰面积与内标峰面积的比值和浓度的线性关系均良好,批内、批间RSD均小于10%。结论本试验所建立的LC-MS/MS分析方法准确、灵敏、方便,可用于莫沙必利的人体药动学研究。 OBJECTIVE A liquid chromatography-tandem mass spe ctrometry(LC-MS/MS)method for the determination of Mosapride in human plasma was developed and validated.METHODS LC-MS/MS method was used with a C 18 column(00B-4454-B0,Gemini 5mNX-C 18110,50×2mm)by the mobile phase A of water(containing 0.2%formic acid)and the mobile phase B of acetonitrile(containing 0.2%formic acid)with the gradient elution.RESULTS The calibration curves of Mosapride were established over the range of 0.200-160ng·mL^-1.The intra-day and inter-day relative standard deviations were less than 10%.CONCLUSION The present LC-MS/MS method was accuracy,sensitive and simple,and can be applied to a pharmacokinetics of Mosapride in human.
作者 朱文玲 熊文刚 伊金玲 王锌源 林美玲 陈彩丽 罗茜 ZHU Wen-ling;XIONG Wen-gang;YIN Jin-ling;WANG Xin-yuan;LIN Mei-ling;CHEN Cai-li;LUO Xi(The first affiliated hospital,School of Medicine,Xiamen university,Xiamen 361000,China;AccuBE PharmaTech,Xiamen 361000,China)
出处 《海峡药学》 2020年第5期32-35,共4页 Strait Pharmaceutical Journal
关键词 莫沙必利 LC-MS/MS 药代动力学 Mosapride Pharmacokinetics LC-MS/MS
  • 相关文献

参考文献3

二级参考文献21

  • 1秦永平,余勤,梁茂植,邹远高.反相高效液相色谱紫外法测定血浆中莫沙必利浓度[J].药物分析杂志,2005,25(2):181-183. 被引量:3
  • 2刘东,刘宇,刘喆隆,张冬林,裘琳,刘异,汪震.枸橼酸莫沙必利口服液与片剂人体生物等效性评价[J].中国医院药学杂志,2006,26(10):1208-1210. 被引量:5
  • 3Yoichi Aoki, Hideki Hakamata. Liquid chromatography tandem mass spectrometric method for determination of mosapride citrate in equine tissues. J Chromatogr B,2007,858 : 135.
  • 4Isao Yokoyama, Yasuyuki Mizuki ,Toshikazu Yamaguchi ,et al. Simultaneos enantiomeric determination of a gastroprokinetic agent mosapride citrate and its metabolite in plasma using α1 - acid glycoprotein HPLC column. J Pharm Biomed Anal, 1997,15 : 1527.
  • 5Yoshida N, Omoya H, Kato S ,et al. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneimittel Forsch, 1993,43 (10) : 1078.
  • 6秦峰,陈凌云,马源源,王东,刘娟,鹿秀梅,李发美.高效液相色谱-质谱/质谱联用法测定人血浆中莫沙必利[J].药学学报,2007,42(8):882-885. 被引量:7
  • 7Yoshikawa T,Yoshida N,Mine Y,et al.Affinity of mosapride citrate,a new gastroprokinetic agent,for 5-HT4receptors in juineapigileum[J].Jpn J Pharmacol,1998,77(1):53-59.
  • 8Kato S,Morie T,Hino K,et al.Novel benzamides as selective and potent gastric prokinetic agent 1.Synthesi and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides[J].J Med Chem,1990,33(5):1406-1413.
  • 9Yoshida N.Pharmacological effects of the gastroprokinetic agent mosapride citrate[J].Nippon Yakurigaku Zasshi,1999,113(5):299-307.
  • 10Ravindra kumar Y,Babu JM,Sarma MSP,et al.Application of LC-MS/MS for the identification of a polar impurity in mosapride,a gastroprokinetic drug[J].J Pharmaceut Biomed,2003,32(2):361-368.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部